Discordant proliferation and differentiation in pituitary tumor-transforming gene-null bone marrow stem cells

被引:13
|
作者
Rubinek, Tami
Chesnokova, Vera
Wolf, Ido
Wawrowsky, Kolja
Vlotides, George
Melmed, Shlomo
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Res Inst, Dept Med, Los Angeles, CA USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2007年 / 293卷 / 03期
关键词
securin; cell cycle; hypoplasia;
D O I
10.1152/ajpcell.00145.2007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mammalian securin, pituitary tumor-transforming gene (Pttg), regulates sister chromatid separation during mitosis. Mice deficient in Pttg expression exhibit organ-specific hypoplasia of the testis, spleen, pituitary, and postmaturity pancreatic beta-cells, pointing to a possible adult stem cell defect. Bone marrow stem cells (BMSCs) contribute to bone, cartilage, and fat tissue repair and regeneration, and multipotent adult progenitor cells (MAPCs) have broader differentiation ability. Bone marrow cells derived under MAPC conditions are involved in a spectrum of tissue repair. We therefore tested whether Pttg deletion affects stem cell proliferation and differentiation. BMSCs were isolated under MAPC conditions, although unlike MAPCs, wild-type (WT) and Pttg(-/-) BMSCs do not express octamer-binding transcription factor 4 and are stem cell antigen-I positive. WT and Pttg(-/-) cells did not differ in their ability to differentiate into adipogenic, osteogenic, or hepatocyte-like cells or in phenotypic markers. Cells underwent > 100 population doublings, with no observed transforming events. Pttg-null BMSCs replicated 27% slower than WT BMSCs, and under hypoxic conditions, this difference widened. Although apoptosis was not enhanced in Pttg(-/-) cells, Pttg(-/-) BMSC senescence-associated beta-galactosidase activity was elevated, consistent with enhanced p21 protein levels. Using gene array assays, DNA repair genes were shown to be upregulated in Pttg(-/-) BMSCs, whereas genes involved in cell cycle progression, including cyclin D-1, were decreased. Separase, the protease regulated by Pttg, has been implicated in DNA damage repair and was downregulated in Pttg(-/-) BMSCs. Separase was constitutively phosphorylated in Pttg(-/-) cells, a modification likely serving as a compensatory mechanism for Pttg deletion. The results indicate that Pttg deletion reduces BMSC proliferation, renders cells more sensitive to hypoxia, and enhances senescent features, thus pointing to a role for Pttg in the maintenance and proliferation of BMSCs.
引用
收藏
页码:C1082 / C1092
页数:11
相关论文
共 50 条
  • [21] Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1
    Tung-Yueh Chuang
    Jie Min
    Hsiao-Li Wu
    Cristina McCrary
    Lawrence C. Layman
    Michael P. Diamond
    Ricardo Azziz
    Ayman Al-Hendy
    Yen-Hao Chen
    Reproductive Sciences, 2017, 24 : 1005 - 1013
  • [22] Effects of silencing connexin43 on expression of pituitary tumor-transforming gene in prolactinomas
    Wang, Haitao
    Zhang, Yaju
    Zhou, Aiqin
    Zhang, Ran
    Meng, Qinghai
    NEUROLOGICAL RESEARCH, 2015, 37 (02) : 153 - 158
  • [23] Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer
    Kim, DS
    Franklyn, JA
    Stratford, AL
    Boelaert, K
    Watkinson, JC
    Eggo, MC
    McCabe, CJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03): : 1119 - 1128
  • [24] The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer
    Kim, Caroline S.
    Ying, Hao
    Willingham, Mark C.
    Cheng, Sheue-Yann
    CARCINOGENESIS, 2007, 28 (05) : 932 - 939
  • [25] Inhibition of Pituitary Tumor-Transforming Gene-1 in Thyroid Cancer Cells by Drugs That Decrease Specificity Proteins
    Chintharlapalli, Sudhakar
    Papineni, Sabitha
    Lee, Syng-Ook
    Lei, Ping
    Jin, Un Ho
    Sherman, Steven I.
    Santarpia, Libero
    Safe, Stephen
    MOLECULAR CARCINOGENESIS, 2011, 50 (09) : 655 - 667
  • [26] Pituitary tumor-transforming gene 1 regulates invasion of prostate cancer cells through MMP13
    Lin, Yun-Hua
    Tian, Yong
    Wang, Jun-Sheng
    Jiang, Yong-Guang
    Luo, Yong
    Chen, Ya-Tong
    TUMOR BIOLOGY, 2016, 37 (12) : 15495 - 15500
  • [27] Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation
    Hatzistergos, Konstantinos E.
    Quevedo, Henry
    Oskouei, Behzad N.
    Hu, Qinghua
    Feigenbaum, Gary S.
    Margitich, Irene S.
    Mazhari, Ramesh
    Boyle, Andrew J.
    Zambrano, Juan P.
    Rodriguez, Jose E.
    Dulce, Raul
    Pattany, Pradip M.
    Valdes, David
    Revilla, Concepcion
    Heldman, Alan W.
    McNiece, Ian
    Hare, Joshua M.
    CIRCULATION RESEARCH, 2010, 107 (07) : 913 - +
  • [28] Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression
    Horwitz, GA
    Miklovsky, I
    Heaney, AP
    Ren, SG
    Melmed, S
    MOLECULAR ENDOCRINOLOGY, 2003, 17 (04) : 600 - 609
  • [29] The effects and mechanisms of clinorotation on proliferation and differentiation in bone marrow mesenchymal stem cells
    Yan, Ming
    Wang, Yongchun
    Yang, Min
    Liu, Yanwu
    Qu, Bo
    Ye, Zhengxu
    Liang, Wei
    Sun, Xiqing
    Luo, Zhuojing
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 460 (02) : 327 - 332
  • [30] Effects of strontium on proliferation and differentiation of rat bone marrow mesenchymal stem cells
    Li, Yunfeng
    Li, Jihua
    Zhu, Songsong
    Luo, En
    Feng, Ge
    Chen, Qianming
    Hu, Jing
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 418 (04) : 725 - 730